Abstract
In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'.
| Original language | English |
|---|---|
| Article number | 10 |
| Number of pages | 1 |
| Journal | Journal of experimental & clinical cancer research : CR |
| Volume | 39 |
| Issue number | 1 |
| DOIs |
|
| Publication status | Published - Jan 13 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Erratum: Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of experimental & clinical cancer research : CR (2019) 38 1 (474))'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS